HETEROZYGOUS LIPOPROTEIN-LIPASE DEFICIENCY DUE TO A MISSENSE MUTATION AS THE CAUSE OF IMPAIRED TRIGLYCERIDE TOLERANCE WITH MULTIPLE LIPOPROTEIN ABNORMALITIES

被引:139
|
作者
MIESENBOCK, G
HOLZL, B
FOGER, B
BRANDSTATTER, E
PAULWEBER, B
SANDHOFER, F
PATSCH, JR
机构
[1] UNIV INNSBRUCK, DEPT MED, DIV CLIN ATHEROSCLEROSIS RES, ANICHSTR 35, A-6020 INNSBRUCK, AUSTRIA
[2] LANDESKRANKENANSTALTEN SALZBURG, DEPT MED 1, A-5020 SALZBURG, AUSTRIA
来源
JOURNAL OF CLINICAL INVESTIGATION | 1993年 / 91卷 / 02期
关键词
HIGH-DENSITY LIPOPROTEIN-2; INTERMEDIATE-DENSITY LIPOPROTEIN; LOW-DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; POSTPRANDIAL LIPEMIA;
D O I
10.1172/JCI116222
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In 16 members of two Austrian families affected by a missense mutation at codon 188 of the lipoprotein lipase (LPL) gene (8 heterozygous and 8 normal subjects), carrier status for the mutation as determined by DNA analysis was related to LPL activity in postheparin plasma, to the magnitude of postprandial lipemia, and to concentration, composition, and size of the major lipoprotein classes of postabsorptive plasma. Carriers exhibited clearly reduced LPL activity, normal fasting triglycerides, but pronounced postprandial lipemia. The carriers' impaired triglyceride tolerance, as evident in the postprandial state of challenge only, was associated with a fasting lipoprotein constellation characterized by (a) enrichment of HDL2 with triglycerides, (b) reduced HDL2-cholesterol, (c) enrichment of VLDL and intermediate density lipoprotein (IDL) with cholesteryl esters, (d) elevated IDL levels, and (e) small-sized LDL. Within any given individual, the degrees of expression of these characteristics were quantitatively and continuously related with each other as well as with the magnitude of lipemia and with LPL activity.
引用
收藏
页码:448 / 455
页数:8
相关论文
共 50 条
  • [41] A MISSENSE MUTATION (ASP(250)-]ASN) IN EXON-6 OF THE HUMAN LIPOPROTEIN-LIPASE GENE CAUSES CHYLOMICRONEMIA IN PATIENTS OF DIFFERENT ANCESTRIES
    MA, YH
    WILSON, BI
    BIJVOET, S
    HENDERSON, HE
    CRAMB, E
    ROEDERER, G
    MURTHY, MRV
    JULIEN, P
    BAKKER, HD
    KASTELEIN, JJP
    BRUNZELL, JD
    HAYDEN, MR
    GENOMICS, 1992, 13 (03) : 649 - 653
  • [42] A NOVEL MISSENSE MUTATION IN THE C-TERMINAL DOMAIN OF LIPOPROTEIN-LIPASE (GLU(410)-]VAL) LEADS TO ENZYME INACTIVATION AND FAMILIAL CHYLOMICRONEMIA
    PREVIATO, L
    GUARDAMAGNA, O
    DUGI, KA
    RONAN, R
    TALLEY, GD
    SANTAMARINAFOJO, S
    BREWER, HB
    JOURNAL OF LIPID RESEARCH, 1994, 35 (09) : 1552 - 1560
  • [43] IRON-DEFICIENCY HYPERLIPIDEMIA IN 18-DAY-OLD RAT PUPS - EFFECTS OF MILK LIPIDS, LIPOPROTEIN-LIPASE, AND TRIGLYCERIDE SYNTHESIS
    SHERMAN, AR
    GUTHRIE, HA
    WOLINSKY, I
    ZULAK, IM
    JOURNAL OF NUTRITION, 1978, 108 (01): : 152 - 162
  • [44] Characteristics of coronary artery disease and lipoprotein abnormalities in patients with heterozygous familial hypercholesterolemia associated with diabetes mellitus or impaired glucose tolerance
    Yanagi, K
    Yamashita, S
    Kihara, S
    Nakamura, T
    Nozaki, S
    Nagai, Y
    Funahashi, T
    KamedaTakemura, K
    Ueyama, Y
    Jiao, S
    Kubo, M
    Tokunaga, K
    Matsuzawa, Y
    ATHEROSCLEROSIS, 1997, 132 (01) : 43 - 51
  • [45] THE FATTY LIVER DYSTROPHY (FLD) MUTATION - A NEW MUTANT MOUSE WITH A DEVELOPMENTAL ABNORMALITY IN TRIGLYCERIDE-METABOLISM AND ASSOCIATED TISSUE-SPECIFIC DEFECTS IN LIPOPROTEIN-LIPASE AND HEPATIC LIPASE ACTIVITIES
    LANGNER, CA
    BIRKENMEIER, EH
    BENZEEV, O
    SCHOTZ, MC
    SWEET, HO
    DAVISSON, MT
    GORDON, JI
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (14) : 7994 - 8003
  • [46] A HETEROZYGOUS MUTATION (THE CODON FOR SER447-]A STOP CODON) IN LIPOPROTEIN-LIPASE CONTRIBUTES TO A DEFECT IN LIPID INTERFACE RECOGNITION IN A CASE WITH TYPE-I HYPERLIPIDEMIA
    KOBAYASHI, J
    NISHIDA, T
    AMEIS, D
    STAHNKE, G
    SCHOTZ, MC
    HASHIMOTO, H
    FUKAMACHI, I
    SAITO, KSY
    YOSHIDA, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (01) : 70 - 77
  • [47] Novel compound heterozygous mutations for lipoprotein lipase deficiency:: a G-to-T transversion at the first position of exon 5 causing G154V missense mutation and a 5′ splice site mutation of intron 8
    Ikeda, Y
    Takagi, A
    Nakata, Y
    Sera, Y
    Hyoudou, S
    Hamamoto, K
    Nishi, Y
    Yamamoto, A
    JOURNAL OF LIPID RESEARCH, 2001, 42 (07) : 1072 - 1081
  • [48] A NEWLY IDENTIFIED HETEROZYGOUS LIPOPROTEIN-LIPASE GENE MUTATION (CYS(239)-]STOP/TGC(972)-]TGA LPL(OBAMA)) IN A PATIENT WITH PRIMARY TYPE-IV HYPERLIPOPROTEINEMIA
    TAKAGI, A
    IKEDA, Y
    MORI, A
    TSUTSUMI, Z
    OIDA, K
    NAKAI, T
    YAMAMOTO, A
    JOURNAL OF LIPID RESEARCH, 1994, 35 (11) : 2008 - 2018
  • [49] Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPLArita in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis
    Kawashiri, M
    Higashikata, T
    Mizuno, M
    Takata, M
    Katsuda, S
    Miwa, K
    Nozue, T
    Nohara, A
    Inazu, A
    Kobayashi, J
    Koizumi, J
    Mabuchi, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12): : 6541 - 6544
  • [50] A NOVEL MISSENSE MUTATION IN THE GENE FOR LIPOPROTEIN-LIPASE RESULTING IN A HIGHLY CONSERVATIVE AMINO-ACID SUBSTITUTION (ASP(180) -] GLU) CAUSES FAMILIAL CHYLOMICRONEMIA (TYPE-I HYPERLIPOPROTEINEMIA)
    HAUBENWALLNER, S
    HORL, G
    SHACHTER, NS
    PRESTA, E
    FRIED, SK
    HOFLER, G
    KOSTNER, GM
    BRESLOW, JL
    ZECHNER, R
    GENOMICS, 1993, 18 (02) : 392 - 396